| Title： | Expert Consensus on Drug Therapy for Inherited Arrhythmia |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians |
| Evidence classification method： | Level of evidence C |
| Development unit： | Chinese Medical Association Electrophysiology and Pacing Branch |
| Registration time: | 2024-10-08 |
| Registration number： | PREPARE-2024CN742 |
| Purpose of the guideline: | Recently, great progress has been made in the study of the genotype and phenotype of hereditary arrhythmias.The treatment strategies have also undergone significant changes. For the treatment of patients with hereditary arrhythmias, medication therapy still plays an important role, which complements interventional and instrumental therapy. |
